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As we pointed out, the proposed mechanism for the interaction
between eproxindine and flupenthixol is speculative. However,
Simister and Jorgensen’s suggestion that this fatality could have
been due to an idiosyncratic reaction to eproxindine is also
speculative. Their comment that the volunteer who died had higher
blood levels of eproxindine than the other volunteer who had
received the same dose sequence is misleading, since in the man who
died the only sample analysed for eproxindine was taken at
necropsy, over 24 h after death. Blood levels of this drug in the two
volunteers cannot therefore be compared.
Simister and Jorgensen also suggest that high blood levels of
unbound active flupenthixol, which could be due to displacement
from protein binding sites, "would only be possible for drugs with a
small apparent volume ofdistribution" whereas "flupenthixol has a
very large volume of distribution". It is, however, possible that
greatly increased amounts of free flupenthixol could have reached
the heart before redistribution of the drug had occurred. In
discussing drug-displacement interactions Lindup and Orme2 point
out that after displacement "the potentiation of pharmacological
activity is transient and fades as a new steady state is established,
during co-administration of the drugs". The time required to reach
a new steady state would clearly be of critical importance in the
present case. The suggestion that a level of free flupenthixol of 0 - 5
ng/ml is equivalent to a total plasma level of 50 ng/ml would only be
true if the extent of protein binding of flupenthixol were exactly
99%. Since the binding of this drug is so high that it cannot be
accurately determined, the equivalent total plasma concentration
could be much higher; for example, if binding were 99 - 9% a free-
drug level of 0-5 5 ng/ml would represent a total plasma
concentration of 500 ng/ml, much higher than therapeutic plasma
levels.
Dr Pereira Gray and Dr Jones and Dr Good (Feb 9, p 343) raised
the question of the medical history of drug-study volunteers. The
difficulty in obtaining a comprehensive medical history for
volunteers participating in phase I studies is a matter of serious
concern to all clinical pharmacologists. We have often discussed the
possibility that consulting the volunteer’s general practitioner
would add to the dimensions of safety in phase I studies. However,
in our experience healthy adults in the 18-25 age group are often
living apart from their family and may not have been seen by their
family doctor for several years. Furthermore, seeking a certificate of
suitability for all volunteers from their GPs would be impracticable
and would place the GPs in a vulnerable position medicolegally,
which few would be prepared to accept. In our opinion, therefore,
the burden of responsibility for making a full disclosure of his
medical history must ultimately rest on the volunteer.
Dr Watkins (this issue) asks why debrillation was attempted when
the patient was asystolic and why cardiac pacing was not done.
Direct current countershock was applied to this volunteer in the
remote hope of inducing a reversible arrhythmia. In the situation of
established asystole without P waves the attendant consultant
physician decided to continue resuscitative procedures and not to
undertake temporary cardiac pacing.
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SODIUM BALANCE IN LOW BIRTHWEIGHT BABIES
AFTER ORAL REHYDRATION
SIR,-Dr Sachdev (Dec 22/29, p 1474) asks why we saw scant
evidence ofhypernatraemia in our low birth weight (LBW) neonates
with diarrhoea on oral rehydration (Oct 6, p 818) when he and his
colleagues saw so much in theirs. We now have experience with 63
LBV- neonates, of whom 3 died; 53 received oral rehydration
therapy (ORT) only. Only 2 had mild, asymptomatic
hypernatraemia. We did not see oedema in any child. We have
reviewed the paper by Sachdev and co-workers’ as well as our own
data and find substantial differences, perhaps instructive. We
believe that our patients were protected against sodium overload for
several reasons. In our patients diarrhoea developed while they were
in our unit and since we knew their pre-illness weight we could
replace their deficits and losses to within a few grams. Sachdev’s
patients were admitted with diarrhoea, and with severe acidosis in
nearly two-thirds. Over 75% of our patients received soy-based
formula 6 h after ORT began (98% after 12 h), with 80% getting it
half strength and thus an ample quantity of free water. 92% of our
children had diarrhoea for less than 1 day (an effect, we believe, of
early feeding), while the average course of diarrhoea in Sachdev’s
patients was about twice as long. It may yet be correct that with
serious and prolonged diarrhoea in LBW neonates a lower
concentration of sodium in the rehydrating and maintenance fluid
produces less imbalance. We stated in our first letter that, "Even
LBW neonates may be safely given deficit therapy using ORT with
the WHO formulation although they are... likely to need ... far
more meticulous attention".
El Galaa Teaching Hospital,
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LEU M1 MONOCLONAL ANTIBODY STAINING OF
REED-STERNBERG CELLS
SIR,-We would like to comment on Professor Wright’s statement
(Feb 9, p 340) about the specificity of the Leu Ml monoclonal
antibody for Reed-Sternberg (RS) cells in Hodgkin’s disease (HD).
Although we found that RS cells and their variants and Hodgkin’s
(H) cells stained with Leu Ml in forty cases of lymphocyte
predominance, nodular sclerosis, and mixed cellularity HD which
had been fixed in B5 or formalin and embedded in paraffin, RS-like
cells also stained with Leu M1 in five of six cases of
immunologically proven T-cell lymphoma. Therefore, it appears
that the Leu Ml monoclonal antibody stains RS-like cells in both T
and B-cell (see Dr Linch and colleagues’ reply to Wright’s letter)
lymphomas and is less specific than originally thought.
Departments of Pathology,
University of Michigan
and VA Medical Center,




SIR,-In a television programme (Horizon, BBC 2, Feb 4) the late
Dr Norman Geshwind, professor of neurology at Harvard
University, expressed the opinion that there might be a link
between migraine and left-handedness. I therefore questioned fifty
consecutive patients with migraine and another fifty with
neurological conditions but without migraine headaches, with the
following results: 
- -
These observations indicate that there is no link between
handedness and migraine. When, as a registrar, I used to put ideas
such as this to my late chief, Lord Brain, he would reply, with
flattening brevity, "Ingenious but incorrect".
National Hospitals for Nervous Diseases,
London WClN 3BG J. N. BLAU
